Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam benzenesulfonate plus alfentanil for sedation in painless gastroscopy
ChiCTR2200058938Phase 4Not yet recruiting
- Sponsor
- Second People's Hospital of Anhui Province
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam in None, sponsored by Second People's Hospital of Anhui Province. Primary endpoints: Sedative effect score, Time of effect of sedation and 7 more. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2200058938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058938.